La Jolla Pharmaceutical Company
COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD

Last updated:

Abstract:

The present disclosure relates to the use of hepcidin, mini-hepcidin, or a hepcidin analogue in therapeutic methods for the treatment and/or prevention of acquired iron overload or other conditions for which iron redistribution or sequestration is helpful.

Status:
Application
Type:

Utility

Filling date:

18 Jan 2018

Issue date:

7 Nov 2019